Last $0.91 USD
Change Today +0.0098 / 1.09%
Volume 978.0K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur T. Sands M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 102 board members in 2 different organizations across 3 different industries.

See Board Relationships
52--
As of Fiscal Year 2013

Background*

Dr. Arthur T. Sands, M.D., Ph.D., has been Chief Executive Officer at Nurix, Inc. since September 2014. Dr. Sands co-founded Lexicon Pharmaceuticals, Inc. (formerly, Lexicon Genetics Inc.) and served as its President and Chief Executive Officer from September 1995 to July 7, 2014. At Lexicon, Dr. Sands pioneered the development of large-scale gene knockout technology for use in drug discovery and guided the evolution of Lexicon from a research-stage company to a drug ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

Director
Director
1995-N/A
Co-Founder

Education*

BA
Yale University
PhD
Baylor College of Medicine
MD
Baylor College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $0.91 USD +0.0098

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.